Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
- Viral Infection
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 381834
University further granted Licensee the right to grant sublicenses. All rights granted to Licensee were reserved to University.
Patent 62/431,550 'Differential Molecular Diagnostic Assay for Zika'
The research program is in the field of CII-ArboViroPlex rRT-PCR Test, a multiplex assay that can simultaneously test, detect and differentiate the Zika virus, all Dengue virus serotypes, Chikungunya virus and West Nile virus. The key advantage of this diagnostic kit is the ability to detect and differentiate almost instantaneously the four viruses.
IPSCIO Record ID: 380354
IPSCIO Record ID: 364018
Zika Virus is a virus that is spread by mosquitoes.
IPSCIO Record ID: 380353
Loop-Mediated Isothermal Amplification (the LAMP) – a patents to develop and make any reagent, product, kit, device, equipment, instrument and/or system for nucleic acid in-vitro diagnostic tests for the detection of a SARS-CoV-2. The main technical methods for COVID-19 testing include reverse transcription loop-mediated isothermal amplification (RT-LAMP), RT-PCR, serology test and antigen test. Nucleic acid amplification test, which includes RT-LAMP and RT-PCR, is the most extensively used in practice because of its high specificity, sensitivity and accuracy. The RT-LAMP technology was used to develop a viral RNA molecular test or nucleic acid amplification test for COVID-19.
IPSCIO Record ID: 380067